Compare WVE & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | HIVE |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2015 | 2017 |
| Metric | WVE | HIVE |
|---|---|---|
| Price | $5.35 | $3.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 8 |
| Target Price | ★ $29.81 | $6.44 |
| AVG Volume (30 Days) | 3.1M | ★ 21.4M |
| Earning Date | 04-28-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,704,000.00 | ★ $297,791,000.00 |
| Revenue This Year | N/A | $169.51 |
| Revenue Next Year | $85.67 | $39.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 149.43 | ★ 158.32 |
| 52 Week Low | $5.01 | $1.73 |
| 52 Week High | $21.73 | $7.84 |
| Indicator | WVE | HIVE |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 51.09 |
| Support Level | $5.02 | $2.63 |
| Resistance Level | $6.39 | $3.40 |
| Average True Range (ATR) | 0.34 | 0.23 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 23.93 | 60.40 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers. Its computing power is used for high-performance computing (HPC) and for generating hashrate sold to mining pools for cryptocurrency mining. The Company uses cash flow from its hashrate services business to support the expansion of its AI and HPC operations through its subsidiary. The Company focuses on Canada, Sweden, and Paraguay, where low-cost renewable power supports its operations and expansion. It operates in one segment with two revenue streams: the mining and sale of digital currencies and high-performance computing hosting. The majority of its revenue is generated from Bermuda.